| # | Drug | Count |
|---|---|---|
| 0 | ATORVASTATIN CALCIUM | 18 |
| 1 | CALCIUM | 18 |
| 2 | CLOZAPINE | 17 |
| 3 | DEXLANSOPRAZOLE | 17 |
| 4 | ERGOCALCIFEROL | 17 |
| 5 | OXYCODONE | 17 |
| 6 | PREGABALIN | 17 |
| 7 | QUETIAPINE | 17 |
| 8 | TOPIRAMATE | 17 |
| 9 | ONDANSETRON | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HALOPERIDOL DECANOATE | 14 | 0.0081 |
| 1 | LEUPROLIDE ACETATE AND NORETHINDRONE ACETATE | 1 | 0.0023 |
| 2 | FOLLICULINUM, OOPHORINUM, | 2 | 0.0007 |
| 3 | DEXLANSOPRAZOLE | 17 | 0.0005 |
| 4 | (SALINE) | 1 | 0.0005 |
| 5 | CIMETIDINE HYDROCHLORIDE | 2 | 0.0005 |
| 6 | AMLODIPINE VALSARTAN AND HYDROCHLOROTHIAZIDE | 1 | 0.0004 |
| 7 | QUETIAPINE FUMARATE | 5 | 0.0004 |
| 8 | METFORMIN HYDROCHLORIDE TABLETS | 9 | 0.0004 |
| 9 | METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS | 9 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Proton Pump Inhibitor [EPC] | 20 |
| 1 | Calcium [EPC] | 18 |
| 2 | Opioid Agonist [EPC] | 18 |
| 3 | Phosphate Binder [EPC] | 18 |
| 4 | Atypical Antipsychotic [EPC] | 17 |
| 5 | Provitamin D2 Compound [EPC] | 17 |
| 6 | Serotonin-3 Receptor Antagonist [EPC] | 16 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 16 |
| 8 | Platinum-based Drug [EPC] | 15 |
| 9 | Corticosteroid [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Progestin Antagonist [EPC] | 1 | 0.0003 |
| 1 | Serotonin-4 Receptor Antagonist [EPC] | 1 | 0.0003 |
| 2 | Serotonin-3 Receptor Antagonist [EPC] | 16 | 0.0002 |
| 3 | Calcium [EPC] | 18 | 0.0002 |
| 4 | Phosphate Binder [EPC] | 18 | 0.0002 |
| 5 | Platinum-based Drug [EPC] | 15 | 0.0001 |
| 6 | Opioid Agonist [EPC] | 18 | 0.0001 |
| 7 | Provitamin D2 Compound [EPC] | 17 | 0.0001 |
| 8 | Purine Antimetabolite [EPC] | 4 | 0.0001 |
| 9 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |